The Delhi government has imposed an immediate ban on the sale, purchase, and distribution of Coldrif Cough Syrup after tests revealed it contained a dangerously high level of a toxic chemical. According to an official order issued on Friday, the syrup, manufactured in May 2025 by Tamil Nadu–based Sresan Pharmaceutical Manufacturer, was found adulterated with Diethylene Glycol (46.28% w/v) — a highly poisonous compound linked to severe health risks and even death. Authorities have urged citizens to discontinue the use of the syrup immediately to prevent any possible health emergencies.

The order, issued by the Delhi Directorate of Health Services, declared the particular batch of Coldrif Syrup (Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate) as “not of standard quality.” Officials have directed all chemists, distributors, and healthcare providers to withdraw the product from shelves and stop its circulation. The advisory emphasized that even minimal exposure to Diethylene Glycol can damage internal organs, especially the kidneys and nervous system, making the syrup unfit for human consumption.

The Delhi government has also called on public health officers and enforcement teams to ensure strict compliance with the ban. Meanwhile, an investigation into the manufacturer’s operations is underway, following the recent arrest of the firm’s owner by Tamil Nadu police in connection with multiple deaths allegedly linked to the same cough syrup. The public has been requested to report any ongoing sale or possession of Coldrif to local drug control authorities to ensure full implementation of the ban.